CD36 and metabolic dysfunction-associated steatohepatitis: Decreased nuclear WTAP in NASH leads to the impairment of the WTAP/HDAC1 axis and increases the transcription of Igfbp1, Cd36 and Ccl2, which further increases lipolysis in WAT, hepatic FFA uptake and liver inflammation, respectively, finally causing NASH pathogenesis.